Skip to main content

and
  1. Article

    Abstracts

    Saiah Michèle, Borgeat Alain, Wilder-Smith Oliver in Canadian Journal of Anaesthesia (1992)

  2. Article

    Erratum

    Saiah Michèle, Borgeat Alain, Wilder-Smith Oliver in Canadian Journal of Anaesthesia (1992)

  3. No Access

    Article

    Transesophageal echocardiography for identifying potential cardiac sources of embolism in patients with stroke

    Pathologies of cerebral circulation are one of the most frequent causes of mortality and morbidity among the populations of Western countries. The incidence of ischemic events presumed to have a cardioembolic...

    A. Palazzuoli, D. Ricci, C. Lenzi, J. Lenzi, V. Palazzuoli in Neurological Sciences (2000)

  4. Article

    229 Fetal Post-Haemorrhagic Ventriculomegaly: Neurological Outcome At 24 Months

    Background: Intraventricular hemorrhage (IVH), a common event in preterm infants, may also occur in utero with a suggested estimate of 1–5 in 10000 pregnancies. A high incidence of sequelae is reported in surv...

    R Luciano, E Mercuri, D Ricci, I Savarese, F Gallini, L Masini in Pediatric Research (2005)

  5. Article

    139 Visual Findings in Infants with Periventricular Leukomalacia

    Aims. The aim of the study was to assess cortical visual function in infants with cystic periventricular leukomalacia (PVL).

    F Gallini, D Ricci, R Luciano, C Romagnoli, M Pane, V Donvito in Pediatric Research (2005)

  6. No Access

    Article

    Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope

    Background: Thyroglobulin autoantibodies (TgAb) can develop in patients with subacute thyroiditis (SAT). Aim: Comparison of the epitope pattern of TgAb of patients with SAT, Hashimoto’s thyroiditis (HT) [autoimm...

    F. Latrofa, D. Ricci, L. Montanelli in Journal of Endocrinological Investigation (2012)

  7. Article

    Open Access

    Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report

    Preterm infants are at risk for neurodevelopmental sequelae even in absence of major cerebral lesions. The hypothesis that Human Recombinant Erythropoietin (rEpo) could improve the neurodevelopmental outcome i...

    R. Luciano, A. Fracchiolla, D. Ricci, F. Cota, V. D’Andrea in Italian Journal of Pediatrics (2015)

  8. Article

    Open Access

    Cerebral Autoregulation in Patients Treated With V-Vecmo For Severe Ards

    V Fanelli, AT Mazzeo, I Battaglini, S Caccia in Intensive Care Medicine Experimental (2015)

  9. Article

    Open Access

    36th International Symposium on Intensive Care and Emergency Medicine

    P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux

    R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis, J. Solé-Violán in Critical Care (2016)

  10. Article

    Open Access

    ESICM LIVES 2016: part two

    S. Sivakumar, F. S. Taccone, K. A. Desai in Intensive Care Medicine Experimental (2016)

  11. Article

    Open Access

    Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine

    Author et al, R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis in Critical Care (2016)

  12. No Access

    Article

    Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy

    A role of the insulin-like growth factor-1 receptor (IGF-1R) in the pathogenesis of Graves’ orbitopathy (GO) has been proposed, but the existence and function of anti-IGF-1R-antibodies (IGF-1R-Abs) are debated.

    M. Marinò, G. Rotondo Dottore, I. Ionni in Journal of Endocrinological Investigation (2019)

  13. No Access

    Article

    Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study

    The insulin-like growth factor-1 receptor (IGF-1R) is a key element in the pathogenesis of Graves’ Orbitopathy (GO), but the role of IGF-1R autoantibodies (IGF-1RAbs) has not been established.

    G. Lanzolla, D. Ricci, F. Nicolì, E. Sabini in Journal of Endocrinological Investigation (2020)